Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Kailera Therapeutics
Kailera Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Kailera Therapeutics
Kailera Therapeutics Summary
Company Summary
Overview
Kailera Therapeutics is a company that develops injectable and oral therapies for the treatment of obesity. It offers injectable and oral peptides, as well as oral small molecules.
Type
Public
Status
Active
Founded
2024
HQ
Waltham, MA, US
|
view all locations
Website
https://www.kailera.com
Cybersecurity rating
Sectors
Healthcare
clinical research
medtech
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Ron Renaud,
President & Chief Executive Officer
Locations
View all
1 location detected
Waltham, MA
HQ
United States
180 3rd Ave 4th floor
Kailera Therapeutics Financials
Summary Financials
Net income (Q1, 2026)
($78.9M)
Cash (Q1, 2026)
$111.8M
EBIT (Q1, 2026)
($84.7M)
Competitors and Similar Companies
Premier Integrity Solutions
Healthcare - Private
IPN Medical Centres
Healthcare - Private
CMAX
Healthcare - Subsidiary
Laboratório Sodré
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top